A new rexinoid for cutaneous t-cell lymphoma
- PMID: 11346343
A new rexinoid for cutaneous t-cell lymphoma
Comment on
-
Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma.Arch Dermatol. 2001 May;137(5):581-93. Arch Dermatol. 2001. PMID: 11346336 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical